Glenview Trust Co

SEC CIK: 0001691827
Latest filing: Aug 18, 2026

SEC filings (opens in a new tab)

ABT holding history

Abbott Laboratories in every 13F filed by Glenview Trust Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overview All 13F holders of ABT Full Q2 2026 holdings

Shares (Q2 2026): 91,591
Value: $8.31M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of ABT by Glenview Trust Co, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	91,591	$8.31M	0.1%	−554−0.6%	Reduced	Holders
Q1 2026	92,145	$9.46M	0.1%	+797+0.9%	Added	Holders
Q4 2025	91,348	$11.4M	0.2%	+494+0.5%	Added	Holders
Q3 2025	90,854	$12.2M	0.2%	−374−0.4%	Reduced	Holders
Q2 2025	91,228	$12.4M	0.2%	+807+0.9%	Added	Holders
Q1 2025	90,421	$12.0M	0.2%	−2,895−3.1%	Reduced	Holders
Q4 2024	93,316	$10.6M	0.2%	+3,821+4.3%	Added	Holders
Q3 2024	89,495	$10.2M	0.2%	+321+0.4%	Added	Holders
Q2 2024	89,174	$9.27M	0.2%	+161+0.2%	Added	Holders
Q1 2024	89,013	$10.1M	0.2%	+3,924+4.6%	Added	Holders
Q4 2023	85,089	$9.37M	0.2%	−1,474−1.7%	Reduced	Holders
Q3 2023	86,563	$8.38M	0.2%	+159+0.2%	Added	Holders
Q2 2023	86,404	$9.42M	0.3%	+941+1.1%	Added	Holders
Q1 2023	85,463	$8.65M	0.3%	+1,014+1.2%	Added	Holders
Q4 2022	84,449	$9.27M	0.3%	+455+0.5%	Added	Holders
Q3 2022	83,994	$8.13M	0.3%	−297−0.4%	Reduced	Holders
Q2 2022	84,291	$9.16M	0.3%	+2,370+2.9%	Added	Holders
Q1 2022	81,921	$9.70M	0.3%	−1,239−1.5%	Reduced	Holders
Q4 2021	83,160	$11.7M	0.4%	+3,861+4.9%	Added	Holders
Q3 2021	79,299	$9.37M	0.4%	+2,252+2.9%	Added	Holders
Q2 2021	77,047	$8.93M	0.3%	+3,301+4.5%	Added	Holders
Q1 2021	73,746	$8.84M	0.4%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.